世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000031755

COVID-19治療薬関連APIの世界市場レポート(2022年)

The Business Research Company

COVID-19 Drug Associated APIs Global Market Report 2022

発刊日 2022/03/02

言語英語

体裁PDF/400ページ

ライセンス/価格400ページ

0000031755

Single
Site
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※受注後、レポートは最新版へ更新されますので、納品までに3〜5営業日かかります。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

本レポートは、戦略担当者、マーケティング担当者、経営幹部に、世界のCOVID-19(新型コロナウイルス感染症)治療薬関連API市場を評価するために必要な重要な情報を提供します。

また、力強い成長を遂げているCOVID-19治療薬関連API市場に焦点を当てています。本レポートは、世界的なパンデミックという課題に対する市場の対応など、今後10年以上にわたって私たちの生活を形作り変化させるCOVID-19治療薬関連API市場へのガイドを提供します。

調査範囲

  • 調査市場
    ➣ 薬剤クラス別
      ◇ 抗マラリア薬
      ◇ 気管支拡張薬
      ◇ 抗生物質
      ◇ 抗ウイルス薬
      ◇ その他
    ➣ 合成タイプ別
      ◇ 合成
      ◇ バイオテクノロジー
    ➣ ビジネスモード別
      ◇ 自社用API
      ◇ 販売用API
  • 調査企業
    ➣ Dr. Reddy's Laboratories
    ➣ Lianyungang Guike Pharmaceutical
    ➣ Alembic Pharmaceutical
    ➣ Wockhardt Ltd.
    ➣ Sandoz Srl
  • 調査国
    ➣ オーストラリア、ブラジル、中国、フランス、ドイツ、インド、インドネシア、日本、ロシア、韓国、イギリス、アメリカ
  • 調査地域
    ➣ アジア太平洋地域
    ➣ 西ヨーロッパ
    ➣ 東ヨーロッパ
    ➣ 北アメリカ
    ➣ 南アメリカ
    ➣ 中東
    ➣ アフリカ
  • 調査期間
    ➣ 5年間の実績データおよび10年間の予測
  • データ
    ➣ 市場規模と成長率の関連市場に対する比率
    ➣ GDP比率
    ➣ 一人当たりの支出
  • データセグメント
    ➣ 国別・地域別の実績および予測データ
    ➣ 競合企業の市場シェア
    ➣ 市場セグメント
  • 情報源および参照
    ➣ 本レポートのデータおよび分析は、注釈で出典を明らかにしています。

レポート詳細

目次

Table of Contents

1. Executive Summary

2. COVID-19 Drug Associated APIs Market Characteristics

3. COVID-19 Drug Associated APIs Market Trends And Strategies

4. Impact Of COVID-19 On COVID-19 Drug Associated APIs

5. COVID-19 Drug Associated APIs Market Size And Growth
5.1. Global COVID-19 Drug Associated APIs Historic Market, 2016-2021, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global COVID-19 Drug Associated APIs Forecast Market, 2021-2026F, 2031F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market

6. COVID-19 Drug Associated APIs Market Segmentation
6.1. Global COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Antimalarials
Bronchodilators
Antibiotics
Antivirals
Others
6.2. Global COVID-19 Drug Associated APIs Market, Segmentation By Synthesis Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Synthetic
Biotech
6.3. Global COVID-19 Drug Associated APIs Market, Segmentation By Business Mode, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Captive API
Merchant API

7. COVID-19 Drug Associated APIs Market Regional And Country Analysis
7.1. Global COVID-19 Drug Associated APIs Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
7.2. Global COVID-19 Drug Associated APIs Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

8. Asia-Pacific COVID-19 Drug Associated APIs Market
8.1. Asia-Pacific COVID-19 Drug Associated APIs Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

9. China COVID-19 Drug Associated APIs Market
9.1. China COVID-19 Drug Associated APIs Market Overview
9.2. China COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

10. India COVID-19 Drug Associated APIs Market
10.1. India COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

11. Japan COVID-19 Drug Associated APIs Market
11.1. Japan COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

12. Australia COVID-19 Drug Associated APIs Market
12.1. Australia COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

13. Indonesia COVID-19 Drug Associated APIs Market
13.1. Indonesia COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

14. South Korea COVID-19 Drug Associated APIs Market
14.1. South Korea COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

15. Western Europe COVID-19 Drug Associated APIs Market
15.1. Western Europe COVID-19 Drug Associated APIs Market Overview
15.2. Western Europe COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

16. UK COVID-19 Drug Associated APIs Market
16.1. UK COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

17. Germany COVID-19 Drug Associated APIs Market
17.1. Germany COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

18. France COVID-19 Drug Associated APIs Market
18.3. France COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

19. Eastern Europe COVID-19 Drug Associated APIs Market
19.1. Eastern Europe COVID-19 Drug Associated APIs Market Overview
19.2. Eastern Europe COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

20. Russia COVID-19 Drug Associated APIs Market
20.1. Russia COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

21. North America COVID-19 Drug Associated APIs Market
21.1. North America COVID-19 Drug Associated APIs Market Overview
21.2. North America COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

22. USA COVID-19 Drug Associated APIs Market
22.1. USA COVID-19 Drug Associated APIs Market Overview
22.2. USA COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

23. South America COVID-19 Drug Associated APIs Market
23.1. South America COVID-19 Drug Associated APIs Market Overview
23.2. South America COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

24. Brazil COVID-19 Drug Associated APIs Market
24.1. Brazil COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

25. Middle East COVID-19 Drug Associated APIs Market
25.1. Middle East COVID-19 Drug Associated APIs Market Overview
25.2. Middle East COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

26. Africa COVID-19 Drug Associated APIs Market
26.1. Africa COVID-19 Drug Associated APIs Market Overview
26.2. Africa COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

27. COVID-19 Drug Associated APIs Market Competitive Landscape And Company Profiles
27.1. COVID-19 Drug Associated APIs Market Competitive Landscape
27.2. COVID-19 Drug Associated APIs Market Company Profiles
27.2.1. Dr. Reddy's Laboratories
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Lianyungang Guike Pharmaceutical
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Alembic Pharmaceutical
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Wockhardt Ltd
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Sandoz Srl
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance

28. COVID-19 Drug Associated APIs Pipeline Analysis

29. Key Mergers And Acquisitions In The COVID-19 Drug Associated APIs Market

30. COVID-19 Drug Associated APIs Market Future Outlook and Potential Analysis

31. Appendix
31.1. Abbreviations
31.2. Currencies
31.3. Research Inquiries
31.4. The Business Research Company
31.5. Copyright And Disclaimer

List of Tables
Table 1: Global Historic Market Growth, 2016-2021, $ Billion
Table 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
Table 3: Global COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 4: Asia-Pacific, COVID-19 Drug Associated APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 5: Asia-Pacific, COVID-19 Drug Associated APIs Market, Segmentation By Business Mode, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 6: Global COVID-19 Drug Associated APIs Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 7: Global COVID-19 Drug Associated APIs Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 8: Asia-Pacific, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 9: China, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 10: India, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 11: Japan, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 12: Australia, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 13: Indonesia, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 14: South Korea, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 15: Western Europe, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 16: UK, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 17: Germany, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 18: France, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 19: Eastern Europe, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 20: Russia, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 21: North America, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 22: USA, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 23: South America, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 24: Brazil, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 25: Middle East, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 26: Africa, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 27: Dr. Reddy's Laboratories Financial Performance
Table 28: Lianyungang Guike Pharmaceutical Financial Performance
Table 29: Alembic Pharmaceutical Financial Performance
Table 30: Wockhardt Ltd Financial Performance
Table 31: Sandoz Srl Financial Performance

List of Figures
Figure 1: Global Historic Market Growth, 2016-2021, $ Billion
Figure 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
Figure 3: Global COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 4: Asia-Pacific, COVID-19 Drug Associated APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 5: Asia-Pacific, COVID-19 Drug Associated APIs Market, Segmentation By Business Mode, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 6: Global COVID-19 Drug Associated APIs Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 7: Global COVID-19 Drug Associated APIs Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 8: Asia-Pacific, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 9: China, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 10: India, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 11: Japan, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 12: Australia, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 13: Indonesia, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 14: South Korea, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 15: Western Europe, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 16: UK, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 17: Germany, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 18: France, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 19: Eastern Europe, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 20: Russia, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 21: North America, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 22: USA, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 23: South America, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 24: Brazil, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 25: Middle East, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 26: Africa, COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 27: Dr. Reddy's Laboratories Financial Performance
Figure 28: Lianyungang Guike Pharmaceutical Financial Performance
Figure 29: Alembic Pharmaceutical Financial Performance
Figure 30: Wockhardt Ltd Financial Performance
Figure 31: Sandoz Srl Financial Performance

この商品のレポートナンバー

0000031755

TOP